Meeting the challenges of transplantation in the 21st century.
Novartis Pharma AG, Basel, Switzerland.
M
M
Bernabeu
D000818:Animals; D015316:Genetic Therapy; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods* / Q000639:trends; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009927:Tissue and Organ Procurement / Q000458:organization & administration; D014180:Transplantation / Q000639:trends*; D014181:Transplantation Immunology; D014183:Transplantation, Heterologous / Q000639:trends
D007166:Immunosuppressive Agents